Olive AI Alternative: Healthcare AI for Care Execution

By Gautamdev Chowdary, co-founder and CTO, Zynix AI · Updated October 27, 2026

Key takeaways

Olive AI shut down in October 2023 after selling its clearinghouse and patient access units to Waystar and its prior authorization unit to Humata Health. The right Olive AI alternative depends on the work Olive did for you: Waystar for revenue cycle, Humata Health for prior authorization, and value-based care platforms such as Zynix AI for outreach and follow-up.

Olive raised over $900M and reached a $4B valuation before winding down, so its former customers have had to re-platform.
Its core products automated revenue cycle work such as eligibility verification, claims and prior authorization, largely through robotic process automation.
Waystar now offers revenue cycle software and Humata Health an AI-driven prior authorization solution, so revenue cycle teams can start there.
Zynix AI focuses on value-based care operations, not the revenue cycle, and is not a clearinghouse.
Evaluate any replacement on EHR integration depth, escalation rules, vendor stability and results measured on your own data.

The Olive AI Landscape Shift

Olive AI was once a high-profile name in healthcare AI, raising over $900M for its automation platform and reaching a $4B valuation. On October 31, 2023 it announced that it would shut down after selling its clearinghouse and patient access units to Waystar and its prior authorization unit to Humata Health, so organizations that were evaluating or using Olive have had to find alternatives that deliver on the promise of healthcare AI automation.

What Made Olive Attractive — and What's Still Needed

Olive's core appeal was automating repetitive healthcare workflows: eligibility verification, claims processing, prior authorization, and revenue cycle tasks. These needs haven't changed. Healthcare organizations still carry a heavy administrative workload.

Next-Generation Healthcare AI: What's Changed

From RPA to AI Agents

Olive relied on Robotic Process Automation — software mimicking human clicks. Modern platforms deploy AI agents that understand context, work within the rules and hours a care team sets, and communicate with patients through natural language across phone, text, and portal channels, escalating to staff when a patient needs a person.

From Administrative to Clinical

The new generation supports the care operations around clinical work: patient outreach, care coordination, post-discharge follow-up, medication adherence check-ins, chronic care check-ins, and quality measure closure, with clinical judgment left to licensed clinicians.

From Point Solutions to Platforms

Modern platforms integrate data, intelligence, agents, and care plans into unified platforms. A single platform handles everything from data ingestion through patient outcome documentation.

How Zynix AI Fills the Gap

Zynix AI combines the automation promise that attracted organizations to Olive with next-generation AI agent capabilities, focused on value-based care operations rather than the revenue cycle. The platform runs AI agents for outreach, scheduling, reminders and post-discharge follow-up and executes deployable care plans. Customer results are published on our case study pages, attributed to each customer, rather than averaged here.

Choosing a replacement by workflow

Start with the work Olive did for you, because its businesses went to different buyers. Its clearinghouse and patient access units went to Waystar and its prior authorization unit to Humata Health, so revenue cycle teams can compare those products first.

Prior authorization deserves a fresh look either way, because payer timelines have tightened. Under the CMS Interoperability and Prior Authorization final rule, Medicare Advantage organizations and Medicaid and CHIP programs, including their managed care plans, must send prior authorization decisions within 72 hours for expedited requests and seven calendar days for standard requests, generally beginning January 1, 2026.

If the gap Olive left is in value-based care operations, such as post-discharge follow-up, wellness visits and care gap outreach, look at platforms built for that work. Zynix is one of them; it is not a clearinghouse, and it keeps clinical decisions with your care team.

Olive AI alternatives: who each option suits

Olive AI alternatives fall into a few groups, because Olive’s businesses went to different buyers. Here is what each option says it does on its own website.

Waystar: bought Olive’s clearinghouse and patient access units. It describes cloud-based software for end-to-end revenue cycle management, including financial clearance work such as verifying insurance benefits and automating prior authorizations. It suits revenue cycle teams that relied on Olive for claims and patient access work.
Humata Health: bought Olive’s prior authorization unit. It describes an AI-driven prior authorization solution for providers, pharmacies and payers. It suits teams whose main Olive workload was prior authorization.
Notable: an AI platform with agents across patient access, revenue cycle management, care operations and the contact center. It suits organizations that want to automate front-office and revenue cycle work and build their own flows.
Zynix AI: the AI operating layer for value-based care. Agents and care plans run outreach, scheduling, reminders and post-discharge follow-up within the rules your team sets, and clinicians make every clinical decision. It suits ACOs, MSOs, health plans and FQHCs that know who needs attention and need the follow-up to happen. It is not a clearinghouse.

Start from the work Olive did for you, then shortlist the group that owns that work today.

Evaluating Your Options

When evaluating Olive AI alternatives, prioritize: care workflow automation (not just admin), AI agents that work within rules your team sets and escalate to staff, healthcare-native AI models, EHR integration depth, implementation speed, and outcomes you can measure on your own data.

Frequently asked questions

What happened to Olive AI?

Olive AI shut down. It announced on October 31, 2023 that it would close after Waystar bought its clearinghouse and patient access business units and Humata Health its prior authorization unit; earlier that year Olive had sold its utilization management business to Availity and a business intelligence solution to BurstIQ. It had raised over $900M and reached a $4B valuation.

What are the main Olive AI alternatives?

It depends on what Olive did for you. For clearinghouse and patient access work, Waystar took over those Olive units and offers revenue cycle software. For prior authorization, Humata Health took over that unit. Notable automates front-office and revenue cycle work with AI agents. For value-based care outreach and follow-up, such as discharges, wellness visits and care gaps, Zynix AI is built for that work.

Which Olive AI alternative fits a value-based care organization?

It depends on the work you need covered. For clearinghouse, patient access or prior authorization products, start with the Waystar and Humata Health offerings that took over Olive's units. If what you need is outreach and follow-up for value-based care programs, such as discharges, wellness visits and care gaps, choose a platform designed around those programs. Our platform comparisons lay out where Zynix fits.

How are AI agents different from RPA bots?

RPA bots repeat scripted clicks inside software, so they suit stable, rules-based back-office steps and break when screens or rules change. AI agents work in conversation: they call and text patients, handle varied replies, book and confirm appointments, and hand off to staff when a patient needs a person. Well-governed agents work within rules and hours the care team sets.

What should we ask an automation vendor after Olive?

Ask about company stability and funding, how your data can be exported if the relationship ends, and whether the vendor signs a business associate agreement and can share a current SOC 2 Type II audit report. Then ask to see the escalation rules, who can change them, which EHRs are connected in production, and how results will be measured on your own data.

Source notes

Healthcare Dive, November 1, 2023: Health AI startup Olive to shut down. https://www.healthcaredive.com/news/olive-ai-shuts-down/698455/

HIT Consultant, October 31, 2023: Olive Shutters Business After Sale to Waystar and Humata Health. https://hitconsultant.net/2023/10/31/olive-shutters-business-after-sale-to-waystar-and-humata-health/

Olive (PR Newswire), June 27, 2022: Olive Unveils New Solution to Automate the Revenue Cycle Management Process. https://www.prnewswire.com/news-releases/olive-unveils-new-solution-to-automate-the-revenue-cycle-management-process-301575352.html

Healthcare Dive, January 25, 2022: The shifting digital health investment landscape in 2022 (names Olive among healthcare-focused robotic process automation technologies). https://www.healthcaredive.com/news/digital-health-VC-investment-landscape-2022/617063/

CMS: CMS Interoperability and Prior Authorization Final Rule CMS-0057-F (fact sheet). https://www.cms.gov/newsroom/fact-sheets/cms-interoperability-prior-authorization-final-rule-cms-0057-f

Waystar (home page). https://www.waystar.com/

Humata Health (home page). https://www.humatahealth.com/

Notable: The AI Platform Purpose-Built for Healthcare (home page). https://www.notablehealth.com/

About the author

Gautamdev Chowdary is co-founder and CTO of Zynix AI, where he leads engineering for the Zynix platform, its AI agents and ZynixLLM.

Olive AI Alternative: Next-Generation Healthcare AI for Care Execution